comparemela.com
Home
Live Updates
MDS Research Expands Treatment Options Across Disease Subsets : comparemela.com
MDS Research Expands Treatment Options Across Disease Subsets
Talha Badar, MBBS, MD, discusses myelodysplastic syndrome risk stratification and the FDA approval of luspatercept for patients with this disease.
Related Keywords
Jacksonville
,
Florida
,
United States
,
Talha Badar
,
International Prognostic Scoring System
,
Mayo Clinic
,
Revised International Prognostic Scoring System
,
Mds
,
Myeloproliferative Neoplasms
,
Bbs
,
D
,
Luspatercept
,
Fda Approval
,
comparemela.com © 2020. All Rights Reserved.